人肝脏原位移植后的血清补体
Serum complement after orthotopic transplantation of the human liver.
作者信息
Torisu M, Yokoyama T, Kohler P F, Durst A L, Martineau G, Schroter G, Amemiya H, Groth C G, Starzl T E
出版信息
Clin Exp Immunol. 1972 Sep;12(1):21-30.
Abstract
In five patients with terminal liver failure, replacement of the diseased liver with a well functioning homograft restored markedly depressed total complement and C4 and C3 to normal levels. Concomitantly, C5 protein also increased. Postoperatively, two patients developed a marked drop in C4 and C3 probably in relation to homograft rejection. In contrast, serum hepatitis and biliary obstruction were not accompanied by significant changes. It is concluded that the liver is an important source of synthesis of C4, C3 and C5 and that complement assays might aid in otherwise equivocal diagnosis of hepatic homograft rejection.
摘要
在5例终末期肝衰竭患者中，用功能良好的同种异体移植物替换病变肝脏后，显著降低的总补体以及C4和C3恢复到正常水平。同时，C5蛋白也增加。术后，两名患者的C4和C3显著下降，可能与同种异体移植物排斥反应有关。相比之下，血清性肝炎和胆道梗阻并未伴随显著变化。结论是肝脏是C4、C3和C5合成的重要来源，补体检测可能有助于对肝同种异体移植排斥反应进行其他难以明确的诊断。
相似文献
1
Serum complement after orthotopic transplantation of the human liver.人肝脏原位移植后的血清补体
Clin Exp Immunol. 1972 Sep;12(1):21-30.
2
[Liver transplantation].[肝移植]
Ugeskr Laeger. 1974 May 6;136(19):1021-7.
3
Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.肝移植术后维持免疫抑制治疗中隔日使用泼尼松。
Clin Transplant. 1995 Aug;9(4):322-5.
4
[Indications for liver transplantation in adults].[成人肝移植的适应证]
J Chir (Paris). 1990 Jun-Jul;127(6-7):334-40.
5
Personal experience with orthotopic liver transplantation.原位肝移植的个人经历。
Transplant Proc. 1972 Dec;4(4):759-71.
6
Liver transplantation: a clinical and immunological appraisal.肝移植：临床与免疫学评估
Prog Liver Dis. 1972;4:433-46.
7
[Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].[肝移植后强效初始免疫抑制的价值。60例前瞻性研究]
Gastroenterol Clin Biol. 1994;18(2):115-22.
8
[Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone].[使用硫唑嘌呤和泼尼松联合治疗慢性进行性（侵袭性）肝炎的长期疗法]
Dtsch Gesundheitsw. 1971 Oct 14;26(42):1965-71.
9
The role of serum hepatitis virus in chronic liver disease.血清肝炎病毒在慢性肝病中的作用。
Trans Assoc Am Physicians. 1969;82:265-77.
10
Hemodynamic alterations caused during orthotopic liver transplantation in humans.人类原位肝移植过程中引起的血流动力学改变。
Surgery. 1971 Dec;70(6):872-5.
引用本文的文献
1
mSphere of Influence: Complement activity beyond systemic circulation-implications in the context of infections.影响范围：补体活性超出体循环——感染背景下的意义
mSphere. 2025 Mar 25;10(3):e0053124. doi: 10.1128/msphere.00531-24. Epub 2025 Feb 7.
2
Local complement activation and modulation in mucosal immunity.黏膜免疫中的局部补体激活与调节
Mucosal Immunol. 2024 Aug;17(4):739-751. doi: 10.1016/j.mucimm.2024.05.006. Epub 2024 Jun 4.
3
The Role of Complement Component C3 in Protection Against Pneumonia-Induced Lung Injury.补体成分 C3 在预防肺炎相关性肺损伤中的作用。
DNA Cell Biol. 2024 Apr;43(4):153-157. doi: 10.1089/dna.2023.0445. Epub 2024 Feb 6.
4
Lung epithelial cell-derived C3 protects against pneumonia-induced lung injury.肺上皮细胞衍生的 C3 可预防肺炎引起的肺损伤。
Sci Immunol. 2023 Feb 3;8(80):eabp9547. doi: 10.1126/sciimmunol.abp9547.
5
Challenge to the Intestinal Mucosa During Sepsis.脓毒症时的肠道黏膜挑战。
Front Immunol. 2019 Apr 30;10:891. doi: 10.3389/fimmu.2019.00891. eCollection 2019.
6
Complement activation correlates with graft damage in baboon-to-human liver xenotransplantation.补体激活与狒狒到人类肝脏异种移植中的移植物损伤相关。
Transplant Proc. 1994 Jun;26(3):1249-50.
7
Quantitative determination of complement components produced by purified hepatocytes.纯化肝细胞产生的补体成分的定量测定。
Clin Exp Immunol. 1984 Jan;55(1):189-96.
8
Serum complement in chronic liver disease.慢性肝病中的血清补体
Gut. 1973 Jun;14(6):451-6. doi: 10.1136/gut.14.6.451.
9
Autopsy findings in a long-surviving liver recipient.一位长期存活的肝脏移植受者的尸检结果。
N Engl J Med. 1973 Jul 12;289(2):82-4. doi: 10.1056/NEJM197307122890207.
10
Differences between plasma and serum complement in patients with chronic liver disease.慢性肝病患者血浆和血清补体的差异
Clin Exp Immunol. 1976 Sep;25(3):403-9.
本文引用的文献
1
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
2
COMPONENTS OF GUINEA PIG COMPLEMENT. I. SEPARATION OF A SERUM FRACTION ESSENTIAL FOR IMMUNE HEMOLYSIS AND IMMUNE ADHERENCE.豚鼠补体的成分。I. 免疫溶血和免疫黏附所必需的血清成分的分离。
J Exp Med. 1963 Nov 1;118(5):767-93. doi: 10.1084/jem.118.5.767.
3
ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.人补体第四成分的分离与描述
J Exp Med. 1963 Sep 1;118(3):447-66. doi: 10.1084/jem.118.3.447.
4
Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence.通过免疫黏附中人红细胞凝集反应来测定补体。
J Immunol. 1963 Jan;90:86-97.
5
Chromatographic resolution of the first component of human complement into three activities.将人类补体的第一成分通过色谱法分离为三种活性。
J Exp Med. 1963 Jun 1;117(6):983-1008. doi: 10.1084/jem.117.6.983.
6
Application of a microtechnique to viral serological investigations.一种微技术在病毒血清学研究中的应用。
J Immunol. 1962 Mar;88:320-9.
7
Serum complement in hepatobiliary diseases.肝胆疾病中的血清补体
Proc Soc Exp Biol Med. 1955 Dec;90(3):606-8. doi: 10.3181/00379727-90-22111.
8
The significance of the complement test in liver diseases with jaundice.补体试验在黄疸型肝病中的意义。
Acta Med Scand. 1953;144(4):268-74. doi: 10.1111/j.0954-6820.1953.tb15696.x.
9
Clinical studies of hemolytic complement and the 11S component.溶血补体及11S成分的临床研究
Am J Med. 1967 Jun;42(6):882-90. doi: 10.1016/0002-9343(67)90069-1.
10
Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.豚鼠血清中溶血补体九种成分的分离、纯化及测定方法
Immunochemistry. 1966 Mar;3(2):111-35. doi: 10.1016/0019-2791(66)90292-8.
Zotero 插件